Investigation of Novel 2-(Chloromethyl)-5-(3, 5-Disubstituted-1H-Indol-2-yl)-1,3,4-Oxadiazole Derivatives as In Vitro, and In Silico Bioactivity Potential: Anti-inflammatory, Anti-TB and Antioxidant Activities Study

被引:0
|
作者
Kumar, K. Harish [1 ]
Sridhar, B. T. [2 ]
Karunakar, Prashantha [3 ]
Nagesh, G. Y. [4 ]
Gupta, Nidhi [5 ]
Jisha, S. P. [6 ]
Basavarajaiah, S. M. [7 ]
机构
[1] Maharani Sci Coll Women, Dept Environm Sci, Mysore 570005, Karnataka, India
[2] Maharani Cluster Univ, Maharani Sci Coll Women, Dept Chem, Benagaluru 560001, Karnataka, India
[3] Visvesvaraya Technol Univ, Dayananda Sagar Coll Engn, Dept Biotechnol, Belagavi 560111, Karnataka, India
[4] Guru Nanak First Grade Coll, Dept Chem, Bidar 585403, Karnataka, India
[5] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Ambala 133207, Haryana, India
[6] GFGC, Dept Chem, Benagaluru 560036, Karnataka, India
[7] Vijaya Coll, Post Grad Dept Chem, RV Rd, Bengaluru 560004, Karnataka, India
来源
CHEMISTRYSELECT | 2024年 / 9卷 / 33期
关键词
ADME; Anti-TB; Anti-oxidant; Cyclooxygenase; Indole; 1,3,4-Oxadiazole; Molecular docking; ANTIMICROBIAL ACTIVITY; 1,3,4-OXADIAZOLE;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of novel 2-(chloromethyl)-5-(3, 5-disubstituted-1H-indol-2-yl)-1,3,4-oxadiazole (3 a-h) derivatives have been synthesized as potential COX inhibitors, anti-TB, and anti-oxidant activities. The structures were confirmed by IR, NMR (1H and 13C) mass spectral techniques. The physicochemical properties, ADME, and drug-likeness profile for the synthesized compounds were evaluated by SwissADME. Based on our interest in indole chemistry and SAR study, foresaid indole compounds were examined for in vitro COX inhibitory activity, anti-TB, and antioxidant activities. The physicochemical and ADME studies were disclosed for newly synthesized compounds. The compounds 3 a,3 b and 3 c recognized outstanding COX-II inhibitions with IC50 values of 0.28, 0.24, and 0.45 mu M compared to standard drugs. The compounds 3 a,and3 b showed outstanding anti-TB activity with MIC value 0.78 mu g/mL. The compounds 3 a,3 b, and 3 c attested outstanding antioxidant activity at 10 mu g/ml with a rate of inhibition of 66.52 %, 68.25 %, and 65.95 % respectively. Finally, the molecular docking studies carried out with cyclooxygenase-2 (PDB ID: 6COX), M. tuberculosis enoyl reductase (INHA) complexed with 1-cyclohexyl-N-(3,5-dichlorophenyl)-5-oxopyrrolidine-3-carboxamide (PDB ID: 4TZK), and cytochrome c peroxidase (PDB ID: 2X08), for all the newly synthesized derivatives. Finally, selected compounds were taken for their molecular dynamic studies. A series of novel 2-(chloromethyl)-5-(3, 5-disubstituted-1H-indol-2-yl)-1,3,4-oxadiazole (3 a-h) derivatives have been synthesized as potential COX inhibitors, anti-TB, and anti-oxidant activities. The structures were confirmed by IR, NMR and mass spectral techniques. The physicochemical properties, ADME, and drug-likeness profile for the synthesized compounds were evaluated by SwissADME. Finally, these compounds were taken for their molecular modelling studies. image
引用
收藏
页数:12
相关论文
共 50 条
  • [1] SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF 5-(2′, 5′-DISUBSTITUTED1H-INDOL-3′-YL)-5H-THIAZOLO [4,3-b]1,3,4-OXADIAZOLE,-1,3,4-THIADIAZOLE,-1,2,4-TRIAZOLE AND THEIR DERIVATIVES
    Saundane, A. R.
    Manjunatha, Yarlakatti
    Walmik, Prabhaker
    HETEROCYCLIC COMMUNICATIONS, 2009, 15 (04) : 303 - 310
  • [2] Synthesis of novel of 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study
    Kashid, Bharat B.
    Salunkhe, Pravin H.
    Dongare, Balasaheb B.
    More, Kishor R.
    Khedkar, Vijay M.
    Ghanwat, Anil A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (12)
  • [3] Synthesis, cytotoxic evaluation of novel 2-((1H-indol-3-yl) methyl)-5-alkyl-1,3,4-oxadiazole and 2-alkyl-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole derivatives
    Vijayendar, Venepally
    Routhu, Sunitha Rani
    Kumar, C. Ganesh
    Jala, Ram Chandra Reddy
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2020, 59 (04): : 465 - 473
  • [4] 2-(5-Bromothiophen-2-yl)-5-[5-(10-ethylphenothiazin-3-yl)thiophen-2-yl]-1,3,4-oxadiazole
    Pan, Yu-Zhen
    Wang, You-Gui
    Liu, Jian-Hui
    Sun, Li-Cheng
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1383 - +
  • [5] 2-(Adamantan-1-yl)-5-(4-nitrophenyl)-1,3,4-oxadiazole
    El-Emam, Ali A.
    Kadi, Adnan A.
    El-Brollosy, Nasser R.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O795 - U2666
  • [6] Synthesis and biological screening of 5-(alkyl(1H-indol-3-yl))-2-(substituted)-1,3,4-oxadiazoles as antiproliferative and anti-inflammatory agents
    Rapolu, Sreevani
    Alla, Manjula
    Bommena, Vittal Rao
    Murthy, Ramalinga
    Jain, Nishant
    Bommareddy, Venkata Ramya
    Bommineni, Madhava Reddy
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 66 : 91 - 100
  • [7] 3-(3,4-Dichlorophenyl)-5-(1H-indol-5-yl)-1,2,4-oxadiazole
    Efimova, Julia A.
    Shetnev, Anton A.
    Baykov, Sergey V.
    Petzer, Anel
    Petzer, Jacobus P.
    MOLBANK, 2023, 2023 (01)
  • [8] Antibacterial and Antifungal Activities of 2-(substituted ether)-5-(1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl)-1,3,4-oxadiazole Derivatives
    Zhang, Teng-Teng
    Wang, Pei-Yi
    Zhou, Jian
    Shao, Wu-Bin
    Fang, He-Shu
    Zhou, Xiang
    Wu, Zhi-Bing
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (04) : 2319 - 2325
  • [9] Novel quinolone substituted 1,3,4-oxadiazole derivatives: design, synthesis, antimicrobial and anti-inflammatory potential
    Sharma, Vishal
    Das, Rina
    Mehta, Dinesh Kumar
    Sharma, Diksha
    MOLECULAR DIVERSITY, 2024,
  • [10] 2-{3,4-Dibutoxy-5-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]thiophen-2-yl}-5-(3-methylphenyl)-1,3,4-oxadiazole
    Han, Lu-Na
    Lu, Ran-Zhe
    Zhang, Min
    Wang, Hai-bo
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : 0622 - U2727